Literature DB >> 8813911

Evaluation of asymptomatic microscopic haematuria--influence and clinical relevance of osmolality and pH on urinary erythrocyte morphology.

M Georgopoulos1, F X Schuster, P Porpaczy, P Schramek.   

Abstract

OBJECTIVE: To determine whether the morphological distinction between 'dysmorphic' and 'eumorphic' erythrocytes in urinary sediment differentiates microscopic haematuria (MH) from reno-parenchymal and post-renal bleeding.
MATERIALS AND METHODS: The erythrocyte morphology of 2145 urinary sediments from 1391 patients with MH was evaluated by interference-contrast microscopy and compared with the osmolality, pH and specific gravity of the urine samples.
RESULTS: Compared with more concentrated urine specimens, samples of < 700 mOsmol/kg showed significantly lower percentages of dysmorphic erythrocytes; there was a similar reduction in this percentage at a pH > or = 7. In addition, erythrocytes lysed in diluted or alkaline urine and therefore, under these conditions, no diagnosis could be made.
CONCLUSION: The assessment of erythrocytes in urinary sediment should be performed only under 'standard conditions', i.e. in concentrated and acidic urine, > or = 700 mOsmol/kg and a pH < 7. The presence of > or = 90% dysmorphic erythrocytes in patients with asymptomatic MH, the absence of proteinuria, a normal blood pressure and normal radiological examination indicates 'reno-parenchymal MH', requiring a long-term follow-up with a routine evaluation twice a year, but no immediate treatment in most cases. In contrast, the presence of > or = 90% eumorphic erythrocytes or even 'mixed' results (10-90% eumorphic erythrocytes) indicates 'post-renal MH', requiring a complete urological evaluation.

Entities:  

Mesh:

Year:  1996        PMID: 8813911     DOI: 10.1046/j.1464-410x.1996.00777.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  1 in total

1.  Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: the urologist's perspective.

Authors:  Kyo Chul Koo; Kwang Suk Lee; Ah Ran Choi; Koon Ho Rha; Sung Joon Hong; Byung Ha Chung
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.